Call Us: +44 (0) 1752 753723[email protected]

Bone marrow cells show promise in degenerative, ischemic retinal diseases

Pilot study suggests a role for autologous intravitreal CD34+ cells. The safety and feasibility of intravitreal autologous CD34+ bone marrow cells as a potential therapy for retinal disease were evaluated in a pilot study. Preliminary findings demonstrated the treatment was feasible and researchers intend to pursue a larger, prospective...